eMedicine Specialties > Otolaryngology and Facial Plastic Surgery > Reconstructive Surgery

Orbital Decompression for Graves Disease: Treatment

Author: Michael Mercandetti, MD, MBA, FACS, Consulting Staff, Department of Surgery, Doctors Hospital of Sarasota
Coauthor(s): Adam J Cohen, MD, Consulting Surgeon, Myers Wyse Center for the Eye; Director, Center for Facial Rejuvenation; Andrew Marc Marlowe, MD, Private Practice, Sarasota, Florida; David J Terris, MD, FACS, Porubsky Professor and Chairman, Department of Otolaryngology, Medical College of Georgia; Peter Levin, MD, Associate Clinical Professor, Department of Ophthalmology, Stanford University Medical Center
Contributor Information and Disclosures

Updated: Nov 10, 2008

Treatment

Medical Therapy

Nonsurgical management of Graves ophthalmopathy involves systemic or retrobulbar corticosteroids and external beam irradiation. In patients for whom these modalities are unsuccessful or those who are not considered candidates, surgical decompression may be considered. Medical treatment can also be used in conjunction with surgical decompression.

Surgical Therapy

The technique for endoscopic medial wall decompression, originally described by Kennedy et al and then Metson et al, is summarized below.7,8 A brief description of the lateral orbital wall decompression, as described by Goldberg et al and other groups, is also included.9

Preoperative Details

All patients undergo a complete head and neck examination and ophthalmologic evaluation followed by coronal and axial CT scanning of the orbits and paranasal sinuses. Visual acuity, visual fields, conjunctival and corneal appearance, Hertel measurements, extraocular motility, and symptoms of diplopia are recorded. Obtain preoperative and postoperative photography.

Prepare the patient for endoscopic sinus surgery under monitored anesthesia care or general anesthesia (the authors' preferred approach). After the administration of parenteral antibiotics and intravenous steroids (eg, dexamethasone, 8-12 mg) and topical (oxymetazoline 0.05%) and local (1% lidocaine, 1:100,000 epinephrine) anesthesia, vasoconstriction is achieved, with particular attention to the middle turbinate and the lateral nasal wall.

Intraoperative Details

Medial Wall Decompression

Endoscopic

Perform a septoplasty first if it is needed for exposure. Following this, perform a total anterior and posterior endoscopic ethmoidectomy with sphenoidotomy (to ensure the most posterior segment of the accessible medial orbital wall has been identified) and extended maxillary antrostomy (to provide inferomedial decompression and as prophylaxis against maxillary sinusitis secondary to ostial narrowing as a result of postoperative edema or scarring). Use a Freer elevator or a similar instrument to fracture the medial orbital wall (lamina papyracea). Then gently remove the lamina, taking care not to violate the periorbita because early release of orbital fat has a tendency to obscure the view. This task may be tedious and requires careful use of several instruments, including a Freer elevator, a nerve hook for anterior bone removal, curettes, and Wilde-Blakesley or similar forceps.

In cosmetic cases, try to preserve a strut of bone between the medial and inferior wall decompression to minimize the risk of diplopia. If inferior decompression is to be performed, use a transconjunctival approach.

When the bone of the medial wall has been completely removed (and usually before the lateral wall is addressed), incise the periorbita to liberate the orbital fat and allow decompression. Limiting the depth of the incision is critical to prevent injury to the rectus muscles (especially the medial rectus) and to minimize bleeding. This is accomplished by using a #12 blade on a #7 Bard-Parker handle. The blade is protected with a Steri-Strip, except for the distal 2-3 mm. This technique ensures a sharp cutting instrument each time. Make 2-4 horizontal periorbital incisions, starting from posterior and extending anteriorly.

Beginning with the inferior incision and sequentially moving to the most superior incision is best. This sequence minimizes the propensity of the orbital fat to obscure the subsequent incisions. For ease of incision and to assist with decompression of the orbital contents into the ethmoid vault, which may require additional effort in an irradiated orbit, apply gentle pressure to the globe during this maneuver. Finally, thin strands of periorbita may persist as bands between the horizontal incisions and should be carefully teased free with a nerve hook or similar instrument.

Transcutaneous

Alternative approaches to the medial wall include a transcutaneous incision (such as those used in an external ethmoidectomy approach and a Lynch-type incision). This incision can be enlarged inferiorly with removal of the medial canthal tendon. The floor of the orbit can also be accessed with this approach. The trochlea, through which the superior oblique tendon passes, should be avoided.

Transcaruncular

Still another approach is the transcaruncular approach.4,10 This approach does not require a cutaneous incision, nor does it require detachment of the medical canthal tendon. In this technique, the entry incision is made medially and posteriorly to the caruncle. This plane allows for access to the posterior lacrimal crest and the more posterior ethmoids.

The medial wall can also be approached with a transcutaneous or transconjunctival approach by continuing the dissection superomedially. Take care to avoid the lacrimal system and the origin of the inferior oblique muscle.

Lateral Wall Decompression

The lateral wall of the orbit may be approached through an upper eyelid incision, lateral incision, lateral canthotomy incision, or vertical incision through the conjunctiva; it may also be approached beneath a coronal flap. The eyelid crease incision may be preferred because it heals well, does not violate the conjunctiva or lateral canthal angle, and allows excellent and rapid access to the orbit.

Carry the eyelid crease incision along a laugh line over the orbital rim, never behind the eyebrow. Use cutting cautery or a laser incisional device to cut through the orbicularis muscle. Leave the orbital septum intact. Laterally, proceed with dissection onto the periosteum of the lateral orbital wall. Using retractors or traction sutures, expose the entire orbital rim. Score the periosteum at the orbital rim and proceed with dissection in the subperiosteal space. Control bleeding from the zygomatico-temporal, zygomatico-facial, or lacrimal foramina with bone wax or cautery. The dissection proceeds to the inferior orbital fissure inferiorly, the frontosphenoidal and frontozygomatic sutures superiorly, and past the zygomaticosphenoidal suture. Use a high-speed drill to break through the thin anterior wall of the lateral orbit and remove the anterior bone with a drill or rongeurs, exposing the temporalis muscle. Remove the bone anteriorly, leaving only a thin bony rim.

Posteriorly, the dissection proceeds into the sphenoid bone, stopping at diploic bleeding or when the dura overlying the temporal lobe is exposed. Use a guarded sickle blade to score the periorbita with 2 vertical strips above and below the level of the lateral rectus muscle. A Freer elevator or forceps may be used to tease out orbital fat.

Orbital Floor Decompression

The orbital floor can be approached in various ways. A direct inferior approach can be via a Caldwell-Luc incision, which is performed transorally in the Ogura approach.4 Alternatively, the maxillary sinus can be entered endoscopically and the bone of the orbital floor removed. Avoid damaging the infraorbital nerve. Nonendoscopic alternatives would consist of a transconjunctival lower eyelid approach or a transcutaneous lower eyelid approach, with or without release of the lateral canthal tendon.

Orbital Roof Decompression

This approach is reserved for when other approaches have been tried or an extensive amount of decompression is required. The roof can often be thinned out while avoiding the lacrimal gland. The roof is often accessed via a coronal approach.

Other Techniques

Fat decompression

A standard transcutaneous or transconjunctival approach is used. The extraconal orbital fat is removed with meticulous hemostasis. Accessing intraconal fat involves a deeper dissection.11

Advancements

The lateral orbital wall can be advanced to provide additional decompression. The anterior lateral wall can be resected, advanced, and plated into its new forward position. Valgus rotations, in which the anterior lateral wall is left intact and the posterior part is removed, can be performed.

Postoperative Details

Nasal packing is not used, and the patient is instructed to avoid nose blowing for at least 2 weeks after surgery.

Follow-up

Carefully evaluate the patients in the early postoperative period to ensure maintenance of presurgical level of vision. Examine patients every 1-2 weeks following surgery to ensure proper wound healing. Then, examine them approximately 3-6 months after surgery, when the final result should be attained; postoperative photography may be done if desired.

Complications

Complications of traditional methods of orbital decompression vary with the approach. Complications include diplopia, blindness, epiphora, brain injury, cerebral spinal fluid (CSF) leak, oral-antral fistula, nasolacrimal duct obstruction, and scarring. The endoscopic approach includes all of those risks except for oral-antral fistula. Optic nerve injury has been reported during orbital decompression for Graves disease, but it is rare and may be less likely with endoscopic control because of improved visualization. Complications can include the new onset of postoperative diplopia among patients who undergo decompression for visual loss.

More on Orbital Decompression for Graves Disease

Overview: Orbital Decompression for Graves Disease
Workup: Orbital Decompression for Graves Disease
Treatment: Orbital Decompression for Graves Disease
Follow-up: Orbital Decompression for Graves Disease
Multimedia: Orbital Decompression for Graves Disease
References

References

  1. Naffziger HC. Progressive exophthalmos following thyroidectomy: its pathology and treatment. Ann Surg. 1931;94:582-586.

  2. Walsh TE, Ogura JH. Transantral orbital decompression for malignant exopthalmos. Laryngoscope. 1957;67:544-549.

  3. Garrity JA, Fatourechi V, Bergstralh EJ, et al. Results of transantral orbital decompression in 428 patients with severe Graves' ophthalmopathy. Am J Ophthalmol. Nov 15 1993;116(5):533-47. [Medline].

  4. Rootman J, Stewart B, Goldberg RA. Orbital Surgery A Conceptual Approach. Philadelphia Pa: Lippincott-Raven Publishers; 1995:353-384.

  5. Ing E, Bednarczuk T. Thyroid Ophthalmopathy. www.emedicine.com. 2005;Ophthalmology.

  6. Phillips PH. Newmann, NJ editor. The Orbit. in Ophthalmology Clinics of North America. 14:1. Philadelphia PA: W.B. Saunders Company; Mar 2001:109-127.

  7. Kennedy DW. Functional endoscopic sinus surgery. Technique. Arch Otolaryngol. Oct 1985;111(10):643-9. [Medline].

  8. Metson R, Dallow RL, Shore JW. Endoscopic orbital decompression. Laryngoscope. Aug 1994;104(8 Pt 1):950-7. [Medline].

  9. Goldberg RA. Advances in surgical rehabilitation in thyroid eye disease. Thyroid. Sep 2008;18(9):989-95. [Medline].

  10. Chang EL, Bernardino CR, Rubin PA. Transcaruncular orbital decompression for management of compressive optic neuropathy in thyroid-related orbitopathy. Plast Reconstr Surg. Sep 2003;112(3):739-47. [Medline].

  11. Trokel S, Kazim M, Moore S. Orbital fat removal. Decompression for Graves orbitopathy. Ophthalmology. May 1993;100(5):674-82. [Medline].

  12. Shepard KG, Levin PS, Terris DJ. Balanced orbital decompression for Graves' ophthalmopathy. Laryngoscope. Nov 1998;108(11 Pt 1):1648-53. [Medline].

  13. Kennedy DW, Goodstein ML, Miller NR, et al. Endoscopic transnasal orbital decompression. Arch Otolaryngol Head Neck Surg. Mar 1990;116(3):275-82. [Medline].

  14. Metson R, Shore JW, Gliklich RE, et al. Endoscopic orbital decompression under local anesthesia. Otolaryngol Head Neck Surg. Dec 1995;113(6):661-7. [Medline].

  15. Ben Simon GJ, Mansury AM, Schwarcz RM, et al. Simultaneous orbital decompression and correction of upper eyelid retraction versus staged procedures in thyroid-related orbitopathy. Ophthalmology. May 2005;112(5):923-32. [Medline].

  16. Baldeschi L, Wakelkamp IM, Lindeboom R, et al. Early versus late orbital decompression in Graves' orbitopathy: a retrospective study in 125 patients. Ophthalmology. May 2006;113(5):874-8. [Medline].

  17. Baldeschi L, MacAndie K, Koetsier E, et al. The influence of previous orbital irradiation on the outcome of rehabilitative decompression surgery in graves orbitopathy. Am J Ophthalmol. Mar 2008;145(3):534-540. [Medline].

  18. Goh MS, McNab AA. Orbital decompression in Graves' orbitopathy: efficacy and safety. Intern Med J. Oct 2005;35(10):586-91. [Medline].

  19. Baldeschi L, Lupetti A, Vu P, et al. Reactivation of Graves' orbitopathy after rehabilitative orbital decompression. Ophthalmology. Jul 2007;114(7):1395-402. [Medline].

  20. Baylis HI, Call NB, Shibata CS. The transantral orbital decompression (Ogura technique) as performed by the ophthalmologist: a series of 24 patients. Ophthalmology. Oct 1980;87(10):1005-12. [Medline].

  21. Bednarczuk T, Kiljanski J, Mrowiec T, et al. T cell interactions with extracellular matrix proteins in patients with thyroid-associated ophthalmopathy. Autoimmunity. 1998;27(4):221-30. [Medline].

  22. Ben Simon GJ, Schwarcz RM, Mansury AM, et al. Minimally invasive orbital decompression: local anesthesia and hand-carved bone. Arch Ophthalmol. Dec 2005;123(12):1671-5. [Medline].

  23. Berke RN. A modified Krönlein operation. Trans Am Ophthalmol Soc. 1953;51:193-231.

  24. DeSanto LW. The total rehabilitation of Graves' ophthalmopathy. Laryngoscope. Oct 1980;90(10 Pt 1):1652-78. [Medline].

  25. Hurwitz JJ, Birt D. An individualized approach to orbital decompression in Graves' orbitopathy. Arch Ophthalmol. May 1985;103(5):660-5. [Medline].

  26. Kasperbauer JL, Hinkley L. Endoscopic orbital decompression for Graves' ophthalmopathy. Am J Rhinol. Nov-Dec 2005;19(6):603-6. [Medline].

  27. Leone CR Jr, Piest KL, Newman RJ. Medial and lateral wall decompression for thyroid ophthalmopathy. Am J Ophthalmol. Aug 15 1989;108(2):160-6. [Medline].

  28. Lyons CJ, Rootman J. Orbital decompression for disfiguring exophthalmos in thyroid orbitopathy. Ophthalmology. Feb 1994;101(2):223-30. [Medline].

  29. Maniglia AJ. Fatal and other major complications of endoscopic sinus surgery. Laryngoscope. Apr 1991;101(4 Pt 1):349-54. [Medline].

  30. Petersen IA, Kriss JP, McDougall IR, et al. Prognostic factors in the radiotherapy of Graves' ophthalmopathy. Int J Radiat Oncol Biol Phys. Aug 1990;19(2):259-64. [Medline].

  31. Seiff SR, Shorr N. Nasolacrimal drainage system obstruction after orbital decompression. Am J Ophthalmol. Aug 15 1988;106(2):204-9. [Medline].

  32. Sewall EC. Operative control of progressive exophthalmos. Arch Otolaryngol Head Neck Surg. 1936;24:621-624.

  33. Shorr N, Neuhaus RW, Baylis HI. Ocular motility problems after orbital decompression for dysthyroid ophthalmopathy. Ophthalmology. Apr 1982;89(4):323-8. [Medline].

  34. Weisman RA, Savino PJ. Management of endocrine orbitopathy. Otolaryngol Clin North Am. Feb 1988;21(1):93-102. [Medline].

  35. Wessler S, Avioli LV. Surgical approach to the ophthalmopathy of Graves' disease. JAMA. Jun 7 1971;216(10):1627-31. [Medline].

  36. Wu CH, Chang TC, Liao SL. Results and predictability of fat-removal orbital decompression for disfiguring graves exophthalmos in an Asian patient population. Am J Ophthalmol. Apr 2008;145(4):755-9. [Medline].

Further Reading

Keywords

Graves disease, orbital decompression, orbital decompression for Graves disease, Grave’s disease, Graves eye disease, Grave disease, Graves' orbitopathy, Graves' ophthalmopathy, endocrine orbitopathy, endocrine ophthalmopathy, endocrine-related proptosis, Graves disease treatment, thyroid ophthalmopathy, thyroid orbitopathy, thyroid-related orbitopathy, thyroid-related ophthalmopathy, thyroid eye disease, thyroid-associated orbitopathy, thyroid-related immune orbitopathy, orbital decompression for Graves' disease, exophthalmos, proptosis, thyroid Graves, thyroid ophthalmopathy

Contributor Information and Disclosures

Author

Michael Mercandetti, MD, MBA, FACS, Consulting Staff, Department of Surgery, Doctors Hospital of Sarasota
Michael Mercandetti, MD, MBA, FACS is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Ophthalmology, American College of Surgeons, American Society for Laser Medicine and Surgery, American Society of Ophthalmic Plastic and Reconstructive Surgery, Association of Military Surgeons of the US, and Sarasota County Medical Society
Disclosure: Nothing to disclose.

Coauthor(s)

Adam J Cohen, MD, Consulting Surgeon, Myers Wyse Center for the Eye; Director, Center for Facial Rejuvenation
Adam J Cohen, MD is a member of the following medical societies: American Academy of Ophthalmology and American College of Surgeons
Disclosure: Nothing to disclose.

Andrew Marc Marlowe, MD, Private Practice, Sarasota, Florida
Andrew Marc Marlowe, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American Tinnitus Association, Florida Medical Association, Medical Society of the State of New York, Sarasota County Medical Society, and Vestibular Disorders Association
Disclosure: Nothing to disclose.

David J Terris, MD, FACS, Porubsky Professor and Chairman, Department of Otolaryngology, Medical College of Georgia
David J Terris, MD, FACS is a member of the following medical societies: Alpha Omega Alpha, American Academy of Otolaryngology-Head and Neck Surgery, American Association for the Advancement of Science, American Bronchoesophagological Association, American College of Surgeons, American Head and Neck Society, Federation of American Societies for Experimental Biology, International Association of Endocrine Surgeons, Phi Beta Kappa, Radiation Research Society, Society of University Otolaryngologists-Head and Neck Surgeons, and Triological Society
Disclosure: Nothing to disclose.

Peter Levin, MD, Associate Clinical Professor, Department of Ophthalmology, Stanford University Medical Center
Peter Levin, MD is a member of the following medical societies: American Academy of Ophthalmology and American Society of Ophthalmic Plastic and Reconstructive Surgery
Disclosure: Nothing to disclose.

Medical Editor

Terance (Terry) Ted Tsue, MD, Vice-Chairman for Administrative Affairs, Professor, Residency Program Director, Department of Otolaryngology-Head and Neck Surgery, University of Kansas School of Medicine
Terance (Terry) Ted Tsue, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Medical Association, American Society for Head and Neck Surgery, Association for Research in Otolaryngology, Johns Hopkins Medical and Surgical Association, Missouri State Medical Association, Phi Beta Kappa, and Society of University Otolaryngologists-Head and Neck Surgeons
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Stephen G Batuello, MD, Consulting Staff, Colorado ENT Specialists
Stephen G Batuello, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American College of Physician Executives, American Medical Association, and Colorado Medical Society
Disclosure: Nothing to disclose.

CME Editor

Christopher L Slack, MD, Otolaryngology-Facial Plastic Surgery, Private Practice, Associated Coastal ENT; Medical Director, Treasure Coast Sleep Disorders
Christopher L Slack, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Medical Association
Disclosure: Nothing to disclose.

Chief Editor

Arlen D Meyers, MD, MBA, Professor, Department of Otolaryngology-Head and Neck Surgery, University of Colorado School of Medicine
Arlen D Meyers, MD, MBA is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Head and Neck Society
Disclosure: Covidien Corp Consulting fee Consulting; US Tobacco Corporation unstricted gift unknown

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.